Janux Therapeutics (JANX) PT Lowered to $24 at BofA Securities

April 28, 2026 1:13 PM

BofA Securities analyst Alex Stranahan lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $24.00 (from $29.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found